ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SCLP Scancell Holdings Plc

10.10
0.00 (0.00%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.10 9.70 10.50 10.10 10.10 10.10 177,070 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -7.83 93.71M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 10.10p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £93.71 million. Scancell has a price to earnings ratio (PE ratio) of -7.83.

Scancell Share Discussion Threads

Showing 17401 to 17422 of 67200 messages
Chat Pages: Latest  708  707  706  705  704  703  702  701  700  699  698  697  Older
DateSubjectAuthorDiscuss
31/8/2018
13:55
Or how cytotoxic t cells are going to get the IND submission in on time?
gazza
31/8/2018
13:54
If you want to talk about the science, tell me how Scancells novel approach is going to reduce cash-burn?
gazza
31/8/2018
13:53
baNANA has said lately on MFFF.
Don’t get personal yet he calls us all Lunatics.
SHOw me I am UNDERwater- well if we have NO shares then we. Ant be underwater but as PLuM has bought LOADS at much higher levels and Does NOT trade then he is a LIAR.
Tell you what if we sent PLUM up in a rocket and it landed on MARS the Martisns would not bother to invade Earth as they wouod CONsider average earthling as a Brainless Low life with a HUGE EGO valuing baNABAs CONtribution way above reality.A not to be trusted specimen who always gets things wrong but able to Survive in SUbterranean caves due to development of big gills due to amount of time spent Underwater and amount of time spent in CONfined soaces(6 x6 to be precise with the toilet in the corner and the locked door).
Pity help anyone that shared a cell with him.

drdobson1
31/8/2018
13:53
"""as such to me you are just a blithering idiot .. and add no value what so ever"""

Not true, I offer an honest opinion as an investor on some of the important commercial issues (as do many others)

On the other hand, you just cut and paste articles that I can find and read myself.

Therefore, it is YOU that add no value. Sorry to be the one to have to tell you mate.

gazza
31/8/2018
13:47
Gazza

at the end of the day you don't post on the science

Scancell is all about the science its the only part that is commercial

as such to me you are just a blithering idiot .. and add no value what so ever

however its fun to watch you tie yourself in knots posting with the other lunatics

as you try to argue both sides of the fence at the same time

so what have i achieved .. A smile

what have you achieved .... Stress

inanaco
31/8/2018
13:42
anyone fancy a kipper?
gazza
31/8/2018
13:41
and that's the best the self-proclaimed great debater can come up with?
gazza
31/8/2018
13:39
no you just support the lunatic ..Lozan

and follow on from his threads with more of it ...

LOL

a share holder who is determined to self destruct his own investment ...

Gazza lovs loz

inanaco
31/8/2018
13:39
Inan,

One other thing:

"""point being is you only post against your own share """

Well I don't. I am a holder and I have realistic expectations regarding risk, reward and timescales. This approach, in my opinion, enhances the reputation and value of the share. I choose to invest as I consider the potential upside is worth the risk and the wait. It may well be a get rich slow scheme but better that than a get poor quick scheme.

I feel my stated views have a far more positive effect than pie in the sky valuations and timescales, especially when the aforementioned have consistently failed to materialise.

gazza
31/8/2018
13:33
Inanaco, there you go again, making things up. I have never criticised SCLP for not keeping to their stated timelines, I never said it WASN'T for very valid reasons in fact I don't think I have used the word "delay". I have never stated that they should "cut corners". That would be ludicrous for an investor to call for, one mess up in a trial would be disastrous.

I have merely stated the obvious and that is:
The longer it takes, the more money will be needed.

Not even you can argue against that statement, can you?

And if you do chose to continue arguing, could you make it about something I have actually said and not something you have dreamed up in your head that I have said (please)

gazza
31/8/2018
13:24
You should work for NASA

every time they cut corners .. for some reason the Rocket fell out of the sky ...

Justification .. exceeded rent budget

inanaco
31/8/2018
13:17
Gazza

point being is you only post against your own share and then side with other lunatics ie tosh and lozan .. = lunatic

for some unkown reason you place your own cynical judgement over sensible reason of delay ...

ie improving moditope from 60% to 100%

somehow you cannot see how this vastly improves the value .. instead you relate this to rent costs and salary ??

a tiny amount compared with the potential benefit gained by 40 more patients per 100 .

even if scancell achieved success in 60% of patients the improved vaccine % numbers would still be relative

inanaco
31/8/2018
12:57
Inanaco: so what is my role ... its called facilitation

Me: So what agreement have you helped us reach? (facilitated)

Inanaco: exactly Facilitating ... Lunacy Gazza

Need I say more?

gazza
31/8/2018
12:50
Someone forgot "the TIME is of the essence" clause!

Of course, if all costs could be negotiated by the drus/trial rather than annual salary, annual lease then time wouldn't matter. Perhaps someone could suggest this at the AGM,

Nobody warned me this was a get rich slow scheme.

gazza
31/8/2018
12:43
"It appears now Lozan considers Time a big issue"
.
When were these VITAL trials originally scheduled to START ???
A BALANCED View would opine... The longer the delay / TIME = FUNDS dwindle = MORE FUNDING likely.
The MORE FUNDING = dilution = The harder to CON folks into the BUY,BUY BUY SCAM
The longer the SCAMMERS sit on LOSSES and DEAD MONEY
The more the SCAMMERS DESERVE to sit on LOSSES and DEAD MONEY
.
The WISE KNOW the score... YOU obviously 'Haven't got' "a F.king Clue "{ I Q }

the real lozan
31/8/2018
12:38
Facilitation - meaning:

""" the act of helping other people to deal with a process or reach an agreement or solution without getting directly involved in the process """

So what agreement have you helped us reach?

As to the meaning of Lozan's posts, they are quite self explanatory. In the absence of revenue being earned or a "deal" (looks unlikey) and given that money is being spent on salaries, buildings etc, there is a strong possibility of another fundraising.

Apparently, many investors feel the same, hence the decline in the share price I think predictions of a Lull were over-optimistic. Perhaps a lull is the best we can hope for.

gazza
31/8/2018
12:27
It appears now Lozan considers Time a big issue

last year it was funding

year before it was funding

and prior to that it was funding

and yet here we are funded ...

what exactly have scancell done to miss the clock ?

only they promised patients treated this year with SCIB1 ... and that can be achieved 30 days after IND

of note we are just leaving August not November

so can you please explain your posts in detail Lozan .. as nobody has a F.king Clue what you are on about

inanaco
31/8/2018
12:26
but you have missed something Lozan

Tosh holds
Gazza Holds
Dobson claims he holds

these 3 support you ?

clear lunacy

inanaco
31/8/2018
12:22
* that has lozan WATCHING YOU and YOUR 'GROUP' going DEEPER 'underwater' ... big time"
.
Lovin it Kev, Lovin it

the real lozan
31/8/2018
12:16
"they seem to forget Scancell"
Whereas,YOU would like everyone to *FORGET* = "NO RISK here", "GO ALL IN", "£1,£6,£8+"
Anon anon
Maybe YOU would also like folks to *FORGET* the 11.60p S P this sits at ???

the real lozan
31/8/2018
12:09
P S -
History clearly SHOWS, it in in FACT the company and the 'GROUP' trHYPERS who ARE the ones making = "endless requests for “extra time”.
Whereas, the REALISTS ponder on the EXTRA TIME being taken
And
The EXTRA COSTS that 'EXTRA TIME' attracts

the real lozan
31/8/2018
12:06
I know one team in the lead ........ its scancell in the Grand Challenge

this is a post Gazza forgot to mention yesterday

we are 8 months into a collaboration study with BioNtech and indeed BioNtech have remained in the Grand Challenge so as yet no negatives have unfolded ... this is the first time since Scancell sold of some MABS that we have a commercial deal at the end of a collaboration identified ie ... a third party license.

the Grand Challenge will deliver hopefully, leading to a £20m investment in the Modi3 program non dilutive for share holders, But what it also shows is, Genentech, ISA pharma and BioNtech are happy with the science as presented, ie the technology behind Moditope how can that not be a Huge Positive ?

CRUK is committing funds to the immunobody program and taking it through the first 2 stages of trial. With Scancell able to take back control at the end of the trials or take a partnership/license role through to commercialisation via a phase 3 trial.. subject to defined data, put that into perspective its a commitment by CRUK probably up to £75m or higher

SCIB1
has engaged the top oncologist centers in the US .... these guys can pick and chose

Dr Keith Flaherty, Director of the Termeer Center for Targeted Therapy at the Massachusetts General Hospital Cancer Center and Professor of Medicine at Harvard Medical School, commented: “Despite the plethora of combination regimens under evaluation in melanoma, we believe that the SCIB1 / Checkpoint Inhibitor combination represents a novel, rational and safe approach that offers considerable clinical potential in a disease that still has significant medical need.”

problem with Tosh he cannot separate the process of synergy between the immune system and PD1 being a consensus across the industry

with "If" we can overcome tolerance

so SCIB1 and PD1 has history in the industry of synergy

why is that ?

we all use the adaptive immune system in one way or another .. its "common" across most immunotherapy treatments that is why they gave it the name immunotherapy

it acts on the immune system

the issue here is Tosh/gazza/dobson/lozan rant about what exactly ?

Inanaco PLC .... pmsl

they seem to forget Scancell

inanaco
Chat Pages: Latest  708  707  706  705  704  703  702  701  700  699  698  697  Older